Michigan 2023-2024 Regular Session

Michigan House Bill HB5340 Compare Versions

Only one version of the bill is available at this time.
OldNewDifferences
11 HOUSE BILL NO. 5340 A bill to amend 1956 PA 218, entitled "The insurance code of 1956," (MCL 500.100 to 500.8302) by adding section 3406dd. the people of the state of michigan enact: Sec. 3406dd. (1) An insurer that delivers, issues for delivery, or renews in this state a health insurance policy that provides coverage for prescription drugs shall provide coverage, without cost sharing, for United States Food and Drug Administration-approved products for pre-exposure prophylaxis with effective antiretroviral therapy for the reduction of risk of HIV infection, including any clinical services necessary for the individual to receive the prescription, such as an HIV test, a physician office visit, or counseling by a pharmacist. (2) An insurer described in subsection (1) shall not exclude or limit coverage for pre-exposure prophylaxis when dispensed or administered by pharmacy personnel. As used in this subsection, "pharmacy personnel" includes a pharmacist, as well as a pharmacy intern or pharmacy technician acting under pharmacist supervision in accordance with applicable law. (3) This section does not require an insurer described in subsection (1) to add coverage for pre-exposure prophylaxis or related services furnished by an out-of-network provider. (4) This section does not require an insurer described in subsection (1) to cover all of the therapeutically equivalent versions without prior authorization or step therapy, if at least 1 therapeutically equivalent version is covered without prior authorization or step therapy. (5) An insurer described in subsection (1) shall not subject pre-exposure prophylaxis to prior authorization or step therapy unless the United States Food and Drug Administration has approved 1 or more therapeutic equivalents of a drug, device, or product for the prevention of HIV. (6) As used in this section: (a) "Cost sharing" means an enrollee's individual financial responsibility associated with receiving specific services, including copayments, coinsurance, and the application of a deductible. Cost sharing does not include the payment of a premium. (b) "HIV" means the human immunodeficiency virus.
22
33
44
55
66
77
88
99
1010
1111
1212
1313
1414
1515
1616
1717
1818
1919
2020
2121
2222
2323 HOUSE BILL NO. 5340
2424
2525
2626
2727 A bill to amend 1956 PA 218, entitled
2828
2929 "The insurance code of 1956,"
3030
3131 (MCL 500.100 to 500.8302) by adding section 3406dd.
3232
3333 the people of the state of michigan enact:
3434
3535 Sec. 3406dd. (1) An insurer that delivers, issues for delivery, or renews in this state a health insurance policy that provides coverage for prescription drugs shall provide coverage, without cost sharing, for United States Food and Drug Administration-approved products for pre-exposure prophylaxis with effective antiretroviral therapy for the reduction of risk of HIV infection, including any clinical services necessary for the individual to receive the prescription, such as an HIV test, a physician office visit, or counseling by a pharmacist.
3636
3737 (2) An insurer described in subsection (1) shall not exclude or limit coverage for pre-exposure prophylaxis when dispensed or administered by pharmacy personnel. As used in this subsection, "pharmacy personnel" includes a pharmacist, as well as a pharmacy intern or pharmacy technician acting under pharmacist supervision in accordance with applicable law.
3838
3939 (3) This section does not require an insurer described in subsection (1) to add coverage for pre-exposure prophylaxis or related services furnished by an out-of-network provider.
4040
4141 (4) This section does not require an insurer described in subsection (1) to cover all of the therapeutically equivalent versions without prior authorization or step therapy, if at least 1 therapeutically equivalent version is covered without prior authorization or step therapy.
4242
4343 (5) An insurer described in subsection (1) shall not subject pre-exposure prophylaxis to prior authorization or step therapy unless the United States Food and Drug Administration has approved 1 or more therapeutic equivalents of a drug, device, or product for the prevention of HIV.
4444
4545 (6) As used in this section:
4646
4747 (a) "Cost sharing" means an enrollee's individual financial responsibility associated with receiving specific services, including copayments, coinsurance, and the application of a deductible. Cost sharing does not include the payment of a premium.
4848
4949 (b) "HIV" means the human immunodeficiency virus.